|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-7-19
|
|
pubmed:abstractText |
High-dose buprenorphine (HDB) treatment began in France in 1996 according to relatively unrestricted prescription rules. Continued heroin injection by patients on HDB maintenance treatment and even HDB injection remain underestimated and may lead to a variety of infectious diseases.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0755-4982
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
719-24
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16026125-Abscess,
pubmed-meshheading:16026125-Adult,
pubmed-meshheading:16026125-Analgesics, Opioid,
pubmed-meshheading:16026125-Buprenorphine,
pubmed-meshheading:16026125-Dose-Response Relationship, Drug,
pubmed-meshheading:16026125-Endocarditis, Bacterial,
pubmed-meshheading:16026125-Female,
pubmed-meshheading:16026125-Heroin Dependence,
pubmed-meshheading:16026125-Humans,
pubmed-meshheading:16026125-Male,
pubmed-meshheading:16026125-Meningitis,
pubmed-meshheading:16026125-Osteomyelitis,
pubmed-meshheading:16026125-Retinitis,
pubmed-meshheading:16026125-Retrospective Studies,
pubmed-meshheading:16026125-Skin Diseases,
pubmed-meshheading:16026125-Substance Abuse, Intravenous
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
[Infectious complications and misuse of high-dose buprenorphine].
|
|
pubmed:affiliation |
Service des maladies infectieuses et tropicales, CHU de Nancy (54).
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
